Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Christopher Kohl"'
Publikováno v:
Journal of Business Economics. 88:617-642
In an early stage of developing emerging technologies, there is often great uncertainty regarding their future success. Companies can reduce this uncertainty by listening to the voice of customers as the customer eventually decides to accept an emerg
Autor:
Christopher Kohl, Markus Rey, Ruben de Kanter, Cyrille Lescop, Maxime Boucher, Magdalena Birker-Robaczewska, Oliver Nayler, Martin Bolli, Sylvie Poirey, Beat Steiner
Publikováno v:
Molecular Pharmacology. 93:109-118
S1P1 (sphingosine-1-phosphate receptor 1) agonists prevent lymphocyte egress from secondary lymphoid organs and cause a reduction in the number of circulating blood lymphocytes. We hypothesized that S1P1 receptor modulators with pathway-selective sig
Autor:
Thierry Bruyère, Eric A. Ertel, Stephanie Enderlin-Paput, Hans H. Locher, Michel Enderlin-Paput, Daniel Ritz, Christopher Kohl, Jean-Christophe Gauvin, Patrick Hess, Jean-Philippe Surivet, Azely Mirre, Daniel Bur, Cornelia Zumbrunn, Georg Rueedi, Christian Hubschwerlen, Peter Seiler
Publikováno v:
Journal of Medicinal Chemistry. 60:3776-3794
There is an urgent unmet medical need for novel antibiotics that are effective against a broad range of bacterial species, especially multidrug resistant ones. Tetrahydropyran-based inhibitors of bacterial type II topoisomerases (DNA gyrase and topoi
Autor:
Thomas Weller, Martin Bolli, Claus Müller, Ruben de Kanter, Markus Rey, Magdalena Birker, Patrick Sieber, Cyrille Lescop, Christopher Kohl, Boris Mathys, Beat Steiner, Patrick Hess, Oliver Nayler
Publikováno v:
European Journal of Medicinal Chemistry. 116:222-238
In a previous communication we reported on the discovery of alkylamino pyridine derivatives (e.g. 1) as a new class of potent, selective and efficacious S1P1 receptor (S1PR1) agonists. However, more detailed profiling revealed that this compound clas
Autor:
Magdalena Birker, Jörg Velker, Patrick Hess, Ruben de Kanter, Oliver Nayler, Markus Rey, Beat Steiner, Martin Bolli, Patrick Sieber, Christopher Kohl, Cyrille Lescop, Thomas Weller
Publikováno v:
European Journal of Medicinal Chemistry. 115:326-341
In a previous communication we reported on the discovery of aminopyridine 1 as a potent, selective and orally active S1P1 receptor agonist. More detailed studies revealed that this compound is phototoxic in vitro. As a result of efforts aiming at eli
Autor:
Daniel Ritz, David R. Andes, Jean-Philippe Surivet, Christopher Kohl, Alex Lepak, Peter Seiler
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:3626-3632
ACT-387042 and ACT-292706 are two novel bacterial topoisomerase inhibitors with broad-spectrum activity against Gram-positive and -negative bacteria, including methicillin-resistant Staphylococcus aureus and penicillin- and fluoroquinolone-resistant
Autor:
Alexander Treiber, Stephan Buchmann, Jérôme Segrestaa, Stephane Delahaye, Christopher Kohl, Patricia N. Sidharta, Ruben de Kanter, Carmela Gnerre
Publikováno v:
Clinical Pharmacokinetics. 55:369-380
Macitentan is a novel dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH). It is metabolized by cytochrome P450 (CYP) enzymes, mainly CYP3A4, to its active metabolite ACT-132577. A physiological-based pharma
Publikováno v:
International Journal of Human-Computer Interaction. 32:39-50
Gaining a better understanding of human–computer interaction in multiple-goal environments, such as driving, is critical as people increasingly use information technology to accomplish multiple tasks simultaneously. Extensive research shows that de
Autor:
Luca, Piali, Magdalena, Birker-Robaczewska, Cyrille, Lescop, Sylvie, Froidevaux, Nicole, Schmitz, Keith, Morrison, Christopher, Kohl, Markus, Rey, Rolf, Studer, Enrico, Vezzali, Patrick, Hess, Martine, Clozel, Beat, Steiner, Martin H, Bolli, Oliver, Nayler
Publikováno v:
Pharmacology Research & Perspectives
Sphingosine‐1‐phosphate receptor 1 (S1P1) modulators sequester circulating lymphocytes within lymph nodes, thereby preventing potentially pathogenic autoimmune cells from exiting into the blood stream and reaching inflamed tissues. S1P1 receptor
Autor:
Magdalena, Birker-Robaczewska, Martin, Bolli, Markus, Rey, Ruben, de Kanter, Christopher, Kohl, Cyrille, Lescop, Maxime, Boucher, Sylvie, Poirey, Beat, Steiner, Oliver, Nayler
Publikováno v:
Molecular pharmacology. 93(2)
S1P